SOAT1 and rheumatoid arthritis: To the best of our knowledge, no study has looked at the relationship between changes in disease activity and changes in CS, pain catastrophizing, and neuropathic pain features that occur with the introduction of a novel treatment targeting the JAK/STAT signaling pathway in active RA patients.